Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
ABBV-969 for Prostate Cancer
Recruiting1 awardPhase 1
Grand Rapids, Michigan
This trial aims to test the safety and effectiveness of a new drug called ABBV-969 for treating advanced prostate cancer. The study will involve giving different doses of ABBV-969 to around
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service